Follicular Lymphoma

Five years after finishing treatment for follicular lymphoma, I reflect on remission, scanxiety, life changes, and the joys and challenges of recovery.

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or more prior treatments.

Feeling like others have it worse can dismiss the real challenges of follicular lymphoma and leave patients without the support they need.

I share how my dog helped me through treatment during the pandemic and how adopting a new one reminds me to keep living and planning for a future beyond cancer.

After her follicular lymphoma diagnosis, Karen Cohn reflects on how cancer reshaped her view of mortality and her choice to keep living fully.

After treatment for follicular lymphoma, I reflect on how cancer, retirement, and loss reshaped my sense of normal and what life looks like now.

Living with follicular lymphoma, I’ve learned many assumptions about cancer, remission and treatment side effects don’t reflect the reality I face.

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue to weigh heavily on me.

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system impacts and lasting social effects.

Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring monitoring and follow-up.

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma responded to therapy while others did not.

When I started receiving treatment for follicular lymphoma, I wasn’t sure what to expect regarding treatment — and a lot of things were unexpected.

I’ve heard that trauma doesn’t make people stronger, and I’ve found that after cancer, I’m not the same person that I was before.

Even if care teams have all of your information on their end, advocating for yourself is still necessary during cancer treatment.

Whenever I get sick, I experience a few side effects that usually go away, but unexplained weight loss becomes a problem for me.

Recently, I met a fellow cancer survivor but after talking with her about cancer, I realized she had a different perspective than I did.

Monjuvi, Revlimid and Rituxan improved progression-free survival among adults with relapsed or refractory follicular lymphoma, topline research showed.

The militaristic terminology of “fighting a disease” does not sit well with me. After being diagnosed, I wasn’t fighting. I was reacting.

When I started experiencing symptoms of an infection, I was worried that my follicular lymphoma had returned.

Having a check-up appointment without receiving any type of scan is good, but also scares me.

“Everything happens for a reason,” is among some of the unhelpful things you can say to someone with cancer.